Aligos Therapeutics, Inc. ALGS

Full chart Compare
Set alert

Price alert · ALGS

All alert types
5.02 USD +0.27 (+5.68%)

At closeNov 4, 2026, 4:00 PM EST

5.02 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

4.72 Day range 5.14
3.98 52-week range 13.69
YTD
-46.14%
1 year
-30.37%

Revenue & Expenses

Other Income → Expenses: $64.11MExpenses → Selling, General & Admin: $20.72MExpenses → Research & Development: $69.45MExpenses → Income Tax: $314.00KOther Operating Income → Expenses: $930.00KGross Profit → Expenses: $1.26MRevenue → Gross Profit: $1.26MRevenue → Cost of Revenue: $930.00KNet Loss → Expenses: $24.19MOther Income$64.11MOther Operating Income$930.00KGross Profit$1.26MNet Loss$24.19MCost of Revenue$930.00KExpenses$90.48MSelling, General & Admin$20.72MResearch & Development$69.45MIncome Tax$314.00KRevenue$2.19M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

ALGS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.19M3.94M15.53M13.91M4.36M
2.19M3.94M15.53M13.91M4.36M
2.19M3.94M15.53M13.91M4.36M
90.17M93.10M103.66M111.49M132.68M
69.45M70.27M73.04M85.08M104.15M
20.72M22.83M30.62M26.41M28.53M
-87.98M-89.15M-88.13M-97.58M-128.32M
-3.92M-4.41M-3.41M-1.64M-132.00K
314.00K331.00K795.00K106.00K143.00K
-24.19M-131.21M-87.68M-96.05M-128.33M
-24.19M-131.21M-87.68M-96.05M-128.33M
-24.19M-131.21M-87.68M-96.05M-128.33M
-24.19M-131.21M-87.68M-96.05M-128.33M
-2.45-20.94-34.20-56.00-80.00
-2.45-20.94-34.20-56.00-80.00
-2.45-20.94-34.20-56.00-80.00
-27.80M-135.29M-90.30M-97.58M-128.32M
-27.80M-135.29M-90.30M-97.58M-128.32M
9.88M6.26M2.56M1.71M1.59M
9.88M6.26M2.56M1.71M1.59M